Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

Stock Information for Avant Technologies Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Avant Technologies Inc

Absci to Participate in the Guggenheim Securities SMID Cap Biotech Conference
Healthcare AI Adoption Accelerates as Industry Eyes $125 Billion Growth by 2028
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
Absci and Invetx Partner to Bring Generative AI Drug Creation Platform to Animal Health
Absci to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Absci to Participate in the 36th Annual Piper Sandler Healthcare Conference
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Absci Appoints Professor Sir Mene Pangalos to its Board of Directors

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.